Swati Dhar
Impact in
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Histone Deacetylase Inhibitors Research 9
- Epigenetics and DNA Methylation 3
- Oncology 9
- Peptidase Inhibition and Analysis 4
- Co-authors
- Anait S. Levenson (15 shared papers)Avinash Kumar (10 shared papers)Agnes M. Rimando (8 shared papers)Kun Li (3 shared papers)Chindo Hicks (1 shared paper)Xu Zhang (3 shared papers)Shubhada Chiplunkar (2 shared papers)Jack R. Lewin (6 shared papers)
- Journals
- Cancer Research (3 papers)Oncotarget (2 papers)The Prostate (1 paper)PLoS ONE (1 paper)Immune Network (1 paper)
- Partner nations
- United StatesIndiaGermany
In The Last Decade
Swati Dhar
22 papers receiving 870 citations
Peers
Comparison fields: 5 of 78
- Geriatrics and Gerontology 257
- Cancer Research 268
- Molecular Biology 527
- Oncology 179
- Biochemistry 37
Countries citing papers authored by Swati Dhar
This map shows the geographic impact of Swati Dhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swati Dhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swati Dhar more than expected).
Fields of papers citing papers by Swati Dhar
This network shows the impact of papers produced by Swati Dhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swati Dhar. The network helps show where Swati Dhar may publish in the future.
Co-authors
The 25 scholars most cited alongside Swati Dhar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 129 | |
| 2 | 2014 | 107 | |
| 3 | 2011 | 103 | |
| 4 | 2013 | 76 | |
| 5 | 2013 | 71 | |
| 6 | 2016 | 53 | |
| 7 | 2013 | 41 | |
| 8 | Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells. | 2010 | 40 |
| 9 | 2017 | 39 | |
| 10 | 2009 | 39 | |
| 11 | 2015 | 38 | |
| 12 | 2017 | 37 | |
| 13 | 2018 | 26 | |
| 14 | 2022 | 26 | |
| 15 | 2018 | 19 | |
| 16 | 2022 | 14 | |
| 17 | 2022 | 10 | |
| 18 | 2008 | 10 | |
| 19 | Targeting MTA1/HIF-1alpha Signaling by Pterostilbene in Combination with Histone Deacetylase Inhibitor Attenuates Prostate Cancer Progression (Open Access) | 2017 | 7 |
| 20 | 2022 | 2 |
About Swati Dhar
Swati Dhar is a scholar working on Molecular Biology, Oncology, Geriatrics and Gerontology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 889 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (9 papers), Sirtuins and Resveratrol in Medicine (7 papers), Prostate Cancer Treatment and Research (4 papers), Peptidase Inhibition and Analysis (4 papers), MicroRNA in disease regulation (4 papers), Immune Cell Function and Interaction (3 papers), Epigenetics and DNA Methylation (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Geriatrics and Gerontology (257 citations), Cancer Research (268 citations), Molecular Biology (527 citations), Oncology (179 citations) and Biochemistry (37 citations). Swati Dhar has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Anait S. Levenson, Avinash Kumar, Agnes M. Rimando, Kun Li, Chindo Hicks, Xu Zhang, Shubhada Chiplunkar, Jack R. Lewin, Alan D. Penman and Guri Tzivion. Their work appears in journals such as Cancer Research, Oncotarget, The Prostate, PLoS ONE and Immune Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.